ID

39169

Beschreibung

Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01435174

Link

https://clinicaltrials.gov/show/NCT01435174

Stichworte

  1. 07.12.19 07.12.19 -
  2. 20.09.21 20.09.21 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

7. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility End-stage Renal Disease NCT01435174

Eligibility End-stage Renal Disease NCT01435174

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
18-74 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
within 50% of ideal body weight and greater than 40 kg
Beschreibung

Ideal Body Weight Percentage | Body Weight

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0421272
UMLS CUI [1,2]
C0439165
UMLS CUI [2]
C0005910
chronic kidney disease (ckd) stage 5 receiving maintenance hemodialysis for at least 3 months
Beschreibung

Chronic kidney disease stage | Maintenance hemodialysis

Datentyp

boolean

Alias
UMLS CUI [1]
C2074731
UMLS CUI [2]
C4040576
native kidney estimated glomerular filtration rate(gfr) < 10 ml/min
Beschreibung

Kidney Native | Estimated Glomerular Filtration Rate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0022646
UMLS CUI [1,2]
C0302891
UMLS CUI [2]
C3811844
no concurrent illness or evidence of infection
Beschreibung

Comorbidity Absent | Communicable Disease Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0332197
able to give informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
qtc interval > 470 msec at echocardiogram (ecg) obtained within the last 6 months
Beschreibung

Prolonged QTc interval Echocardiography

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1560305
UMLS CUI [1,2]
C0013516
concomitant qt-prolonging drugs, major p-gp inhibitors, and cyp3a4 inducers and inhibitors including: cyclosporine, rifampin, rifabutin, rifapentine, phenobarbital, phenytoin, carbamazepine, st. john's wort, ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, saquinavir, quinidine, dofetilide, sotalol, amiodarone, erythromycin, thioridazine, ziprasidone, haloperidol, trimethoprim/sulfamethoxazole, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin
Beschreibung

Pharmaceutical Preparations Causing Prolonged QT interval | P-Glycoprotein Inhibitors Major | CYP3A4 Inducers | CYP3A4 Inhibitors | Cyclosporine | Rifampin | Rifabutin | rifapentine | Phenobarbital | Phenytoin | Carbamazepine | ST. JOHN'S WORT EXTRACT | Ketoconazole | Itraconazole | Clarithromycin | nefazodone | Nelfinavir | Ritonavir | Indinavir | Saquinavir | Quinidine | dofetilide | Sotalol | Amiodarone | Erythromycin | Thioridazine | ziprasidone | Haloperidol | Trimethoprim | Sulfamethoxazole | Ciprofloxacin | Norfloxacin | Levofloxacin | moxifloxacin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0151878
UMLS CUI [2,1]
C3500483
UMLS CUI [2,2]
C0205164
UMLS CUI [3]
C3850041
UMLS CUI [4]
C3850053
UMLS CUI [5]
C0010592
UMLS CUI [6]
C0035608
UMLS CUI [7]
C0140575
UMLS CUI [8]
C0073372
UMLS CUI [9]
C0031412
UMLS CUI [10]
C0031507
UMLS CUI [11]
C0006949
UMLS CUI [12]
C0813171
UMLS CUI [13]
C0022625
UMLS CUI [14]
C0064113
UMLS CUI [15]
C0055856
UMLS CUI [16]
C0068485
UMLS CUI [17]
C0525005
UMLS CUI [18]
C0292818
UMLS CUI [19]
C0376637
UMLS CUI [20]
C0286738
UMLS CUI [21]
C0034414
UMLS CUI [22]
C0114771
UMLS CUI [23]
C0037707
UMLS CUI [24]
C0002598
UMLS CUI [25]
C0014806
UMLS CUI [26]
C0039943
UMLS CUI [27]
C0380393
UMLS CUI [28]
C0018546
UMLS CUI [29]
C0041041
UMLS CUI [30]
C0038689
UMLS CUI [31]
C0008809
UMLS CUI [32]
C0028365
UMLS CUI [33]
C0282386
UMLS CUI [34]
C0536495
pre-study hemoglobin < 9.5 g/dl
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
plasma albumin < 2.5 g/dl
Beschreibung

Plasma albumin level

Datentyp

boolean

Alias
UMLS CUI [1]
C1272106
liver disease - exclude subjects with a child pugh score of c or higher
Beschreibung

Liver disease Child-Pugh Classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C2347612
positive pregnancy test
Beschreibung

Pregnancy test positive

Datentyp

boolean

Alias
UMLS CUI [1]
C0240802
breastfeeding
Beschreibung

Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
allergy to ranolazine
Beschreibung

Hypersensitivity Ranolazine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0073633
participating in another investigational study
Beschreibung

Study Subject Participation Status | Clinical Research

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008972
hepatitis b infection due to dialysis isolation requirements
Beschreibung

Hepatitis B | Etiology Dialysis Isolation procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0011946
UMLS CUI [2,3]
C0204727
unstable blood pressure control
Beschreibung

Control of blood pressure Unstable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1753303
UMLS CUI [1,2]
C0443343
need for routine large fluid removal during dialysis (> 4l)
Beschreibung

Removal Fluid Large | Dialysis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1883720
UMLS CUI [1,2]
C0005889
UMLS CUI [1,3]
C0549177
UMLS CUI [2]
C0011946

Ähnliche Modelle

Eligibility End-stage Renal Disease NCT01435174

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18-74 years of age
boolean
C0001779 (UMLS CUI [1])
Ideal Body Weight Percentage | Body Weight
Item
within 50% of ideal body weight and greater than 40 kg
boolean
C0421272 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0005910 (UMLS CUI [2])
Chronic kidney disease stage | Maintenance hemodialysis
Item
chronic kidney disease (ckd) stage 5 receiving maintenance hemodialysis for at least 3 months
boolean
C2074731 (UMLS CUI [1])
C4040576 (UMLS CUI [2])
Kidney Native | Estimated Glomerular Filtration Rate
Item
native kidney estimated glomerular filtration rate(gfr) < 10 ml/min
boolean
C0022646 (UMLS CUI [1,1])
C0302891 (UMLS CUI [1,2])
C3811844 (UMLS CUI [2])
Comorbidity Absent | Communicable Disease Absent
Item
no concurrent illness or evidence of infection
boolean
C0009488 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
able to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prolonged QTc interval Echocardiography
Item
qtc interval > 470 msec at echocardiogram (ecg) obtained within the last 6 months
boolean
C1560305 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
Pharmaceutical Preparations Causing Prolonged QT interval | P-Glycoprotein Inhibitors Major | CYP3A4 Inducers | CYP3A4 Inhibitors | Cyclosporine | Rifampin | Rifabutin | rifapentine | Phenobarbital | Phenytoin | Carbamazepine | ST. JOHN'S WORT EXTRACT | Ketoconazole | Itraconazole | Clarithromycin | nefazodone | Nelfinavir | Ritonavir | Indinavir | Saquinavir | Quinidine | dofetilide | Sotalol | Amiodarone | Erythromycin | Thioridazine | ziprasidone | Haloperidol | Trimethoprim | Sulfamethoxazole | Ciprofloxacin | Norfloxacin | Levofloxacin | moxifloxacin
Item
concomitant qt-prolonging drugs, major p-gp inhibitors, and cyp3a4 inducers and inhibitors including: cyclosporine, rifampin, rifabutin, rifapentine, phenobarbital, phenytoin, carbamazepine, st. john's wort, ketoconazole, itraconazole, clarithromycin, nefazodone, nelfinavir, ritonavir, indinavir, saquinavir, quinidine, dofetilide, sotalol, amiodarone, erythromycin, thioridazine, ziprasidone, haloperidol, trimethoprim/sulfamethoxazole, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin
boolean
C0013227 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0151878 (UMLS CUI [1,3])
C3500483 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C3850041 (UMLS CUI [3])
C3850053 (UMLS CUI [4])
C0010592 (UMLS CUI [5])
C0035608 (UMLS CUI [6])
C0140575 (UMLS CUI [7])
C0073372 (UMLS CUI [8])
C0031412 (UMLS CUI [9])
C0031507 (UMLS CUI [10])
C0006949 (UMLS CUI [11])
C0813171 (UMLS CUI [12])
C0022625 (UMLS CUI [13])
C0064113 (UMLS CUI [14])
C0055856 (UMLS CUI [15])
C0068485 (UMLS CUI [16])
C0525005 (UMLS CUI [17])
C0292818 (UMLS CUI [18])
C0376637 (UMLS CUI [19])
C0286738 (UMLS CUI [20])
C0034414 (UMLS CUI [21])
C0114771 (UMLS CUI [22])
C0037707 (UMLS CUI [23])
C0002598 (UMLS CUI [24])
C0014806 (UMLS CUI [25])
C0039943 (UMLS CUI [26])
C0380393 (UMLS CUI [27])
C0018546 (UMLS CUI [28])
C0041041 (UMLS CUI [29])
C0038689 (UMLS CUI [30])
C0008809 (UMLS CUI [31])
C0028365 (UMLS CUI [32])
C0282386 (UMLS CUI [33])
C0536495 (UMLS CUI [34])
Hemoglobin measurement
Item
pre-study hemoglobin < 9.5 g/dl
boolean
C0518015 (UMLS CUI [1])
Plasma albumin level
Item
plasma albumin < 2.5 g/dl
boolean
C1272106 (UMLS CUI [1])
Liver disease Child-Pugh Classification
Item
liver disease - exclude subjects with a child pugh score of c or higher
boolean
C0023895 (UMLS CUI [1,1])
C2347612 (UMLS CUI [1,2])
Pregnancy test positive
Item
positive pregnancy test
boolean
C0240802 (UMLS CUI [1])
Breast Feeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
Hypersensitivity Ranolazine
Item
allergy to ranolazine
boolean
C0020517 (UMLS CUI [1,1])
C0073633 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Research
Item
participating in another investigational study
boolean
C2348568 (UMLS CUI [1])
C0008972 (UMLS CUI [2])
Hepatitis B | Etiology Dialysis Isolation procedure
Item
hepatitis b infection due to dialysis isolation requirements
boolean
C0019163 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0011946 (UMLS CUI [2,2])
C0204727 (UMLS CUI [2,3])
Control of blood pressure Unstable
Item
unstable blood pressure control
boolean
C1753303 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Removal Fluid Large | Dialysis
Item
need for routine large fluid removal during dialysis (> 4l)
boolean
C1883720 (UMLS CUI [1,1])
C0005889 (UMLS CUI [1,2])
C0549177 (UMLS CUI [1,3])
C0011946 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video